Dr Kevin K Pandya, MD - Medicare Nephrology in Naperville, IL

Dr Kevin K Pandya, MD is a medicare enrolled "Internal Medicine - Nephrology" physician in Naperville, Illinois. He went to University Of Pittsburgh School Of Medicine and graduated in 2003 and has 21 years of diverse experience with area of expertise as Nephrology. He is a member of the group practice Nephrology Associates Of Northern Illinois Ltd, Nani-ihp Llc, Edward Health Ventures and his current practice location is 120 Spalding Dr Ste 410, Nephrology Associates Of Northern Illinois, Naperville, Illinois. You can reach out to his office (for appointments etc.) via phone at (630) 369-0780.

Dr Kevin K Pandya is licensed to practice in Illinois (license number 036114970) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1972759298.

Contact Information

Dr Kevin K Pandya, MD
120 Spalding Dr Ste 410, Nephrology Associates Of Northern Illinois,
Naperville, IL 60540-6558
(630) 369-0780
(630) 369-0886



Physician's Profile

Full NameDr Kevin K Pandya
GenderMale
SpecialityNephrology
Experience21 Years
Location120 Spalding Dr Ste 410, Naperville, Illinois
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Dr Kevin K Pandya attended and graduated from University Of Pittsburgh School Of Medicine in 2003
  NPI Data:
  • NPI Number: 1972759298
  • Provider Enumeration Date: 08/18/2008
  • Last Update Date: 01/25/2023
  Medicare PECOS Information:
  • PECOS PAC ID: 3173676459
  • Enrollment ID: I20090804000455

Medical Identifiers

Medical identifiers for Dr Kevin K Pandya such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1972759298NPI-NPPES
036114970MedicaidIL

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207RN0300XInternal Medicine - Nephrology 036114970 (Illinois)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Fmc - Plainfield NorthPlainfield, ILDialysis facility
Fmc - PlainfieldPlainfield, ILDialysis facility
Fmc - Naperville North Dialysis CenterNaperville, ILDialysis facility
Edward HospitalNaperville, ILHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Nephrology Associates Of Northern Illinois Ltd216332867597
Nani-ihp Llc33757674866
Edward Health Ventures4284531484510

News Archive

UC San Diego Health System named recipient of Distinguished Hospital Award for Clinical Excellence

UC San Diego Health System is a recipient of Healthgrades' "Distinguished Hospital Award for Clinical Excellence." Top performing hospitals were selected based on clinical excellence across a broad spectrum of care in specialty areas such as cardiac and neuro surgery and gastrointestinal, pulmonary and critical care.

Study may offer an unexpected pathway for targeted treatment of brain tumors

In a new study led by Yale Cancer Center, researchers show the nucleoside transporter ENT2 may offer an unexpected path to circumventing the blood-brain barrier (BBB) and enabling targeted treatment of brain tumors with a cell-penetrating anti-DNA autoantibody.

Novel method identifies new oncogene that contributes to development of cancer

A team of researchers at Case Western Reserve University School of Medicine, led by Dr. Mark W. Jackson, have developed a novel method to identify genes that, when overexpressed, make normal cells behave like cancer cells.

CTF, DELopen jointly offer unique opportunities to neurofibromatosis research community

The Children's Tumor Foundation, an innovative and global neurofibromatosis (NF) research foundation announced today a collaboration with DELopen, a DNA-encoded library technology platform sponsored by WuXi AppTec, a leading global provider of R&D and manufacturing services enabling companies in the pharmaceutical, biotechnology and medical device industries.

Researchers say hCNT1 protein may affect cancer cells physiology, apart from transport function

The protein hCNT1, which plays a major role in nucleoside transport, may have other biological functions that may affect cancer cells physiology, apart from their transport function. This is the main conclusion of the new scientific work published on the journal Cell Death and Disease.

Read more Medical News

› Verified 2 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Kevin K Pandya allows following entities to bill medicare on his behalf.
Entity NameNephrology Associates Of Northern Illinois Ltd
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1124069182
PECOS PAC ID: 2163328675
Enrollment ID: O20031208000313

News Archive

UC San Diego Health System named recipient of Distinguished Hospital Award for Clinical Excellence

UC San Diego Health System is a recipient of Healthgrades' "Distinguished Hospital Award for Clinical Excellence." Top performing hospitals were selected based on clinical excellence across a broad spectrum of care in specialty areas such as cardiac and neuro surgery and gastrointestinal, pulmonary and critical care.

Study may offer an unexpected pathway for targeted treatment of brain tumors

In a new study led by Yale Cancer Center, researchers show the nucleoside transporter ENT2 may offer an unexpected path to circumventing the blood-brain barrier (BBB) and enabling targeted treatment of brain tumors with a cell-penetrating anti-DNA autoantibody.

Novel method identifies new oncogene that contributes to development of cancer

A team of researchers at Case Western Reserve University School of Medicine, led by Dr. Mark W. Jackson, have developed a novel method to identify genes that, when overexpressed, make normal cells behave like cancer cells.

CTF, DELopen jointly offer unique opportunities to neurofibromatosis research community

The Children's Tumor Foundation, an innovative and global neurofibromatosis (NF) research foundation announced today a collaboration with DELopen, a DNA-encoded library technology platform sponsored by WuXi AppTec, a leading global provider of R&D and manufacturing services enabling companies in the pharmaceutical, biotechnology and medical device industries.

Researchers say hCNT1 protein may affect cancer cells physiology, apart from transport function

The protein hCNT1, which plays a major role in nucleoside transport, may have other biological functions that may affect cancer cells physiology, apart from their transport function. This is the main conclusion of the new scientific work published on the journal Cell Death and Disease.

Read more Medical News

› Verified 2 days ago

Entity NameEdward Health Ventures
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1962452912
PECOS PAC ID: 4284531484
Enrollment ID: O20031216000616

News Archive

UC San Diego Health System named recipient of Distinguished Hospital Award for Clinical Excellence

UC San Diego Health System is a recipient of Healthgrades' "Distinguished Hospital Award for Clinical Excellence." Top performing hospitals were selected based on clinical excellence across a broad spectrum of care in specialty areas such as cardiac and neuro surgery and gastrointestinal, pulmonary and critical care.

Study may offer an unexpected pathway for targeted treatment of brain tumors

In a new study led by Yale Cancer Center, researchers show the nucleoside transporter ENT2 may offer an unexpected path to circumventing the blood-brain barrier (BBB) and enabling targeted treatment of brain tumors with a cell-penetrating anti-DNA autoantibody.

Novel method identifies new oncogene that contributes to development of cancer

A team of researchers at Case Western Reserve University School of Medicine, led by Dr. Mark W. Jackson, have developed a novel method to identify genes that, when overexpressed, make normal cells behave like cancer cells.

CTF, DELopen jointly offer unique opportunities to neurofibromatosis research community

The Children's Tumor Foundation, an innovative and global neurofibromatosis (NF) research foundation announced today a collaboration with DELopen, a DNA-encoded library technology platform sponsored by WuXi AppTec, a leading global provider of R&D and manufacturing services enabling companies in the pharmaceutical, biotechnology and medical device industries.

Researchers say hCNT1 protein may affect cancer cells physiology, apart from transport function

The protein hCNT1, which plays a major role in nucleoside transport, may have other biological functions that may affect cancer cells physiology, apart from their transport function. This is the main conclusion of the new scientific work published on the journal Cell Death and Disease.

Read more Medical News

› Verified 2 days ago

Entity NameCentral Dupage Physician Group
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1033149844
PECOS PAC ID: 5890696231
Enrollment ID: O20040303000601

News Archive

UC San Diego Health System named recipient of Distinguished Hospital Award for Clinical Excellence

UC San Diego Health System is a recipient of Healthgrades' "Distinguished Hospital Award for Clinical Excellence." Top performing hospitals were selected based on clinical excellence across a broad spectrum of care in specialty areas such as cardiac and neuro surgery and gastrointestinal, pulmonary and critical care.

Study may offer an unexpected pathway for targeted treatment of brain tumors

In a new study led by Yale Cancer Center, researchers show the nucleoside transporter ENT2 may offer an unexpected path to circumventing the blood-brain barrier (BBB) and enabling targeted treatment of brain tumors with a cell-penetrating anti-DNA autoantibody.

Novel method identifies new oncogene that contributes to development of cancer

A team of researchers at Case Western Reserve University School of Medicine, led by Dr. Mark W. Jackson, have developed a novel method to identify genes that, when overexpressed, make normal cells behave like cancer cells.

CTF, DELopen jointly offer unique opportunities to neurofibromatosis research community

The Children's Tumor Foundation, an innovative and global neurofibromatosis (NF) research foundation announced today a collaboration with DELopen, a DNA-encoded library technology platform sponsored by WuXi AppTec, a leading global provider of R&D and manufacturing services enabling companies in the pharmaceutical, biotechnology and medical device industries.

Researchers say hCNT1 protein may affect cancer cells physiology, apart from transport function

The protein hCNT1, which plays a major role in nucleoside transport, may have other biological functions that may affect cancer cells physiology, apart from their transport function. This is the main conclusion of the new scientific work published on the journal Cell Death and Disease.

Read more Medical News

› Verified 2 days ago

Entity NameNorthshore University Healthsystem Faculty Practice Associates
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1497701882
PECOS PAC ID: 2163334699
Enrollment ID: O20040524000118

News Archive

UC San Diego Health System named recipient of Distinguished Hospital Award for Clinical Excellence

UC San Diego Health System is a recipient of Healthgrades' "Distinguished Hospital Award for Clinical Excellence." Top performing hospitals were selected based on clinical excellence across a broad spectrum of care in specialty areas such as cardiac and neuro surgery and gastrointestinal, pulmonary and critical care.

Study may offer an unexpected pathway for targeted treatment of brain tumors

In a new study led by Yale Cancer Center, researchers show the nucleoside transporter ENT2 may offer an unexpected path to circumventing the blood-brain barrier (BBB) and enabling targeted treatment of brain tumors with a cell-penetrating anti-DNA autoantibody.

Novel method identifies new oncogene that contributes to development of cancer

A team of researchers at Case Western Reserve University School of Medicine, led by Dr. Mark W. Jackson, have developed a novel method to identify genes that, when overexpressed, make normal cells behave like cancer cells.

CTF, DELopen jointly offer unique opportunities to neurofibromatosis research community

The Children's Tumor Foundation, an innovative and global neurofibromatosis (NF) research foundation announced today a collaboration with DELopen, a DNA-encoded library technology platform sponsored by WuXi AppTec, a leading global provider of R&D and manufacturing services enabling companies in the pharmaceutical, biotechnology and medical device industries.

Researchers say hCNT1 protein may affect cancer cells physiology, apart from transport function

The protein hCNT1, which plays a major role in nucleoside transport, may have other biological functions that may affect cancer cells physiology, apart from their transport function. This is the main conclusion of the new scientific work published on the journal Cell Death and Disease.

Read more Medical News

› Verified 2 days ago

Entity NameWillow Springs Surgery Center Ltd
Entity TypePart B Supplier - Ambulatory Surgical Center
Entity IdentifiersNPI Number: 1467429233
PECOS PAC ID: 5092783712
Enrollment ID: O20040921000585

News Archive

UC San Diego Health System named recipient of Distinguished Hospital Award for Clinical Excellence

UC San Diego Health System is a recipient of Healthgrades' "Distinguished Hospital Award for Clinical Excellence." Top performing hospitals were selected based on clinical excellence across a broad spectrum of care in specialty areas such as cardiac and neuro surgery and gastrointestinal, pulmonary and critical care.

Study may offer an unexpected pathway for targeted treatment of brain tumors

In a new study led by Yale Cancer Center, researchers show the nucleoside transporter ENT2 may offer an unexpected path to circumventing the blood-brain barrier (BBB) and enabling targeted treatment of brain tumors with a cell-penetrating anti-DNA autoantibody.

Novel method identifies new oncogene that contributes to development of cancer

A team of researchers at Case Western Reserve University School of Medicine, led by Dr. Mark W. Jackson, have developed a novel method to identify genes that, when overexpressed, make normal cells behave like cancer cells.

CTF, DELopen jointly offer unique opportunities to neurofibromatosis research community

The Children's Tumor Foundation, an innovative and global neurofibromatosis (NF) research foundation announced today a collaboration with DELopen, a DNA-encoded library technology platform sponsored by WuXi AppTec, a leading global provider of R&D and manufacturing services enabling companies in the pharmaceutical, biotechnology and medical device industries.

Researchers say hCNT1 protein may affect cancer cells physiology, apart from transport function

The protein hCNT1, which plays a major role in nucleoside transport, may have other biological functions that may affect cancer cells physiology, apart from their transport function. This is the main conclusion of the new scientific work published on the journal Cell Death and Disease.

Read more Medical News

› Verified 2 days ago

Entity NameNani-ihp Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1417376385
PECOS PAC ID: 3375767486
Enrollment ID: O20140611001371

News Archive

UC San Diego Health System named recipient of Distinguished Hospital Award for Clinical Excellence

UC San Diego Health System is a recipient of Healthgrades' "Distinguished Hospital Award for Clinical Excellence." Top performing hospitals were selected based on clinical excellence across a broad spectrum of care in specialty areas such as cardiac and neuro surgery and gastrointestinal, pulmonary and critical care.

Study may offer an unexpected pathway for targeted treatment of brain tumors

In a new study led by Yale Cancer Center, researchers show the nucleoside transporter ENT2 may offer an unexpected path to circumventing the blood-brain barrier (BBB) and enabling targeted treatment of brain tumors with a cell-penetrating anti-DNA autoantibody.

Novel method identifies new oncogene that contributes to development of cancer

A team of researchers at Case Western Reserve University School of Medicine, led by Dr. Mark W. Jackson, have developed a novel method to identify genes that, when overexpressed, make normal cells behave like cancer cells.

CTF, DELopen jointly offer unique opportunities to neurofibromatosis research community

The Children's Tumor Foundation, an innovative and global neurofibromatosis (NF) research foundation announced today a collaboration with DELopen, a DNA-encoded library technology platform sponsored by WuXi AppTec, a leading global provider of R&D and manufacturing services enabling companies in the pharmaceutical, biotechnology and medical device industries.

Researchers say hCNT1 protein may affect cancer cells physiology, apart from transport function

The protein hCNT1, which plays a major role in nucleoside transport, may have other biological functions that may affect cancer cells physiology, apart from their transport function. This is the main conclusion of the new scientific work published on the journal Cell Death and Disease.

Read more Medical News

› Verified 2 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Kevin K Pandya is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Kevin K Pandya, MD
120 W 22nd St Ste 200,
Oak Brook, IL 60523-1563

Ph: (630) 573-5000
Dr Kevin K Pandya, MD
120 Spalding Dr Ste 410, Nephrology Associates Of Northern Illinois,
Naperville, IL 60540-6558

Ph: (630) 369-0780

News Archive

UC San Diego Health System named recipient of Distinguished Hospital Award for Clinical Excellence

UC San Diego Health System is a recipient of Healthgrades' "Distinguished Hospital Award for Clinical Excellence." Top performing hospitals were selected based on clinical excellence across a broad spectrum of care in specialty areas such as cardiac and neuro surgery and gastrointestinal, pulmonary and critical care.

Study may offer an unexpected pathway for targeted treatment of brain tumors

In a new study led by Yale Cancer Center, researchers show the nucleoside transporter ENT2 may offer an unexpected path to circumventing the blood-brain barrier (BBB) and enabling targeted treatment of brain tumors with a cell-penetrating anti-DNA autoantibody.

Novel method identifies new oncogene that contributes to development of cancer

A team of researchers at Case Western Reserve University School of Medicine, led by Dr. Mark W. Jackson, have developed a novel method to identify genes that, when overexpressed, make normal cells behave like cancer cells.

CTF, DELopen jointly offer unique opportunities to neurofibromatosis research community

The Children's Tumor Foundation, an innovative and global neurofibromatosis (NF) research foundation announced today a collaboration with DELopen, a DNA-encoded library technology platform sponsored by WuXi AppTec, a leading global provider of R&D and manufacturing services enabling companies in the pharmaceutical, biotechnology and medical device industries.

Researchers say hCNT1 protein may affect cancer cells physiology, apart from transport function

The protein hCNT1, which plays a major role in nucleoside transport, may have other biological functions that may affect cancer cells physiology, apart from their transport function. This is the main conclusion of the new scientific work published on the journal Cell Death and Disease.

Read more News

› Verified 2 days ago


Internal Medicine Doctors in Naperville, IL

Ehab Ghassan Dababneh, MD
Nephrology
Medicare: Accepting Medicare Assignments
Practice Location: 801 S Washington St Fl 4, Naperville, IL 60540
Phone: 630-600-0700    Fax: 630-600-0701
Dinesh Jain, M.D.
Nephrology
Medicare: Accepting Medicare Assignments
Practice Location: 1243 Rickert Dr, Naperville, IL 60540
Phone: 630-527-6450    Fax: 630-527-6456
Ravi Nemivant, MD
Nephrology
Medicare: Accepting Medicare Assignments
Practice Location: 100 Spalding Dr, Ste 102, Naperville, IL 60540
Phone: 630-871-6699    
Dr. Hoda A. El- Asmar, MD
Nephrology
Medicare: Not Enrolled in Medicare
Practice Location: 801 S Washington St, Edward Hospital, Administration, Vpma Office, Naperville, IL 60540
Phone: 630-527-5647    Fax: 630-527-3702
Gregory Trevino, MD
Nephrology
Medicare: Accepting Medicare Assignments
Practice Location: 608 S Washington St Ste 201, Naperville, IL 60540
Phone: 630-717-2630    
Dr. Mark F Daniels, M.D.
Nephrology
Medicare: Not Enrolled in Medicare
Practice Location: 100 Spalding Dr, Ste 208, Naperville, IL 60540
Phone: 630-355-8000    
Rafael Piedra, MD
Nephrology
Medicare: Not Enrolled in Medicare
Practice Location: 100 Spalding Dr, Ste 208, Naperville, IL 60540
Phone: 630-717-2600    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.